This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

South Carolina To Host Seventh Annual Tour DaVita In September

Stocks in this article: DVA

DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the seventh annual Tour DaVita® – a three-day, 220-mile bike ride to raise awareness and funds for the fight against kidney disease – will kick off on September 15 at the Cherokee Youth Sports Complex in Gaffney, S.C.

“We see Tour DaVita as not only a way to celebrate our teammates and the care they provide patients each day, but also a vehicle to raise awareness of kidney disease and funds for kidney disease programs,” said DaVita Chief Wisdom Officer Steve Priest, director of the event. “The ride continues to grow every year because of our teammates’ and sponsors’ dedication to the fight against kidney disease.”

Tour DaVita 2013 boasts the highest ever rider participation in the history of the event with more than 600 DaVita teammates, dialysis patients, physicians, sponsors, family members and friends of the company taking part. The event has the following itinerary for 2013:

Sept. 15 – Participants will ride 60 miles from Gaffney to Chester
Sept. 16 – Participants will choose either an 80- or 100-mile route from Chester to Fountain Inn
Sept. 17 – Participants will ride 60 miles from Fountain Inn to Seneca
 

Along the way, riders will pass through Brattonsville and McConnells on day one; Lockhart, Buffalo, West Springs and Enoree on day two; and Piedmont, Golden Grove, Pelzer and Pendleton on day three.

To participate in Tour DaVita, riders each raise a minimum of $750 to $2,000 in donations and pay their own travel expenses. Their individual fundraising combined with donations from DaVita and other corporate sponsorship is expected to contribute more than $700,000 to The Kidney TRUST™, a 501(c)(3) independent nonprofit organization that seeks to reduce the progression of chronic kidney disease through no-cost, rapid screening in non-medical settings.

More than 100 Tour DaVita participants have signed up to have their kidneys screened at no cost by The Kidney TRUST during this year’s event.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs